Dimethaid proposes name change to Nuvo Research
Dimethaid Research Inc. announced that it is planning to change its name to Nuvo Research Inc., reflecting the Company's change in direction and focus.
"We have restructured our operations and adopted a new strategic direction. A new name will be a clear signal that we have changed as a Company," said John London, Vice Chairman of Dimethaid. Under the direction of a new Board of Directors and management team, Dimethaid has refocused its efforts on drug development. The Company has initiated a market-driven pipeline and is looking to foster new partnerships with leading companies that are prepared to share the financial risks and rewards of clinical development and are well positioned to commercialize approved drugs.
Nuvo Research was selected following a competition amongst employees, giving them a more personal stake in the Company's identity.
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.